• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Molecular Data Inc.

    10/27/22 9:15:54 AM ET
    $MKD
    Business Services
    Consumer Discretionary
    Get the next $MKD alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-39167
    Issuer: Molecular Data Inc.
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 11/F, Building 15
    2177 Shenkun Road
    Minhang District Shanghai CHINA 201106
    Telephone number: 8,613,816,118,342
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    American Depositary Shares
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2022-10-27 By Aravind Menon Hearings Advisor
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MKD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MKD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MKD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molecular Data Inc. Receives NASDAQ Notification

      SHANGHAI, June 24, 2022  /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced that it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that to date, it has not regained compliance with the Rule 5250(c)(1). Since the Company is already before a Hearings Panel for its failure to comply with the $1.00 minimum bid price requirement set forth in Listing Rule 5550(a)(2),pursuant to Listing Rule 5810(d)(2), rather than submit a compliance plan for Staff's review, the Company is to address the matter before the Hearings Panel. About Molecular Data, Inc. Molecular Data Inc. is a

      6/24/22 5:15:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • Molecular Data Inc. Receives NASDAQ Notification Regarding Minimum Bid Requirements

      SHANGHAI, May 27, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced today that on May 25, 2021, it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that its minimum closing bid price per share for its ordinary shares had fallen below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). On November 29, 2021, the Company was provided with an additional 180 calendar day compliance period, or until May 23, 2022, to demonstrate compliance. On May 24, 2022, th

      5/27/22 10:53:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • Molecular Data Inc. Announces ADS Ratio Change

      SHANGHAI, May 20, 2022 /PRNewswire/ -- Molecular Data Inc. (NASDAQ:MKD) (the "Company") announced today a ratio change on its American Depositary Shares ("ADS") from the current one (1) ADS representing three (3) Class A ordinary shares to the new ratio of one (1) ADS representing forty-five (45) Class A ordinary shares (the "Ratio Change"). The effective date of the Ratio Change is expected to be May 23, 2022. Each ADS holder of record at the close of business on the date when the change in ADS ratio is effective will be required to surrender and exchange every fifteen (15) existing ADSs then held for one (1) new ADS. JPMorgan Chase Bank, N.A., as the depositary bank for the Company's ADS p

      5/20/22 12:14:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    Leadership Updates

    Live Leadership Updates

    See more
    • WATERDROP ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR

      BEIJING, May 2, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE:WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced the appointment of Mr. Ning Zhu as a new independent director to its board of directors (the "Board") and the resignation of Mr. Peng Shen as a member of the audit committee of the Board, both effective May 2, 2022. Mr. Zhu will also serve as a member of the audit committee of the Board. After the change, the Board will consist of nine members, three of whom are independent directors, and the audit committee will consist solely of independent directors. Mr. Ning Zhu has b

      5/2/22 8:00:00 AM ET
      $MKD
      $WDH
      Business Services
      Consumer Discretionary
      Specialty Insurers
      Finance
    • Molecular Data Inc. Announces Changes of Chief Financial Officer

      SHANGHAI, China, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that the Company has appointed Mr. Steven Foo as the new chief financial officer, effective December 1, 2020. Mr. Zhaohong Li has tendered his resignation as chief financial officer, for personal reasons. “We greatly appreciate the contributions that Zhaohong has made during his tenure with the Company, leading our IPO, and building a public company finance team. We respect Zhaohong’s decision and wish him the very best in his future pursuits,” said Dr. Dongliang Chang, Founder and Chair

      12/2/20 7:00:00 AM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Molecular Data Inc.

      SC 13G - Molecular Data Inc. (0001758736) (Subject)

      2/5/24 9:48:58 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)

      SC 13G/A - Molecular Data Inc. (0001758736) (Subject)

      10/5/23 12:01:56 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)

      SC 13G/A - Molecular Data Inc. (0001758736) (Subject)

      2/9/23 9:25:36 PM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    SEC Filings

    See more
    • SEC Form 25-NSE filed by Molecular Data Inc.

      25-NSE - Molecular Data Inc. (0001758736) (Subject)

      10/27/22 9:15:54 AM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Molecular Data Inc.

      6-K - Molecular Data Inc. (0001758736) (Filer)

      5/27/22 5:00:13 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Molecular Data Inc.

      6-K - Molecular Data Inc. (0001758736) (Filer)

      5/20/22 11:58:23 AM ET
      $MKD
      Business Services
      Consumer Discretionary